MNBTD
VNDA icon

Moody National Bank Trust Division’s Vanda Pharmaceuticals VNDA Stock Holding History

Moody National Bank Trust Division’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-154
Closed -$4K – 1390
2018
Q4 		$4K Buy
+154
New +$3.62K ﹤0.01% 1010
2013
Q3 		– Sell
-25,755
Closed -$208K – 248
2013
Q2 		$208K Buy
+25,755
New +$173K 0.02% 219

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Moody National Bank Trust Division's VNDA Position: Q1 2019 in Review

Moody National Bank Trust Division sold out of Vanda Pharmaceuticals (VNDA) in Q1 2019, closing a stake of 154 shares — an estimated $4K sold.

Moody National Bank Trust Division first reported a position in VNDA in Q2 2013 and held it in 2 quarters. The position peaked at $208K in Q2 2013. 179 funds tracked by Wall St. Rank hold VNDA as of Q1 2019.

  • Moody National Bank Trust Division reported no remaining Vanda Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • Moody National Bank Trust Division sold 154 Vanda Pharmaceuticals shares in Q1 2019, an estimated $4K.
  • Moody National Bank Trust Division first reported a position in Vanda Pharmaceuticals in Q2 2013 and held it in 2 quarters.
  • Moody National Bank Trust Division's Vanda Pharmaceuticals position peaked at $208K in Q2 2013.
  • 179 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2019.

Based on Moody National Bank Trust Division's 13F filing for Q1 2019, filed 11 Apr 2019.